Modulation of host innate immune response in the bladder by uropathogenic Escherichia coli. - Wikidata - wikimedia - TriplyDB

Modulation of host innate immune response in the bladder by uropathogenic Escherichia coli.

Modulation of host innate immune response in the bladder by uropathogenic Escherichia coli.

http://www.wikidata.org/entity/Q36313895

about

Subversion of Host Innate Immunity by Uropathogenic Escherichia coli Controversies and challenges in research on urogenital schistosomiasis-associated bladder cancer A novel mouse model of Schistosoma haematobium egg-induced immunopathology Reciprocal regulation between proinflammatory cytokine-induced inducible NO synthase (iNOS) and connexin43 in bladder smooth muscle cells Escherichia coli colonizing the neurogenic bladder are similar to widespread clones causing disease in patients with normal bladder function.Waging war against uropathogenic Escherichia coli: winning back the urinary tract G-CSF induction early in uropathogenic Escherichia coli infection of the urinary tract modulates host immunity.Attenuation of human neutrophil migration and function by uropathogenic bacteria.Comparison of host response mechanisms evoked by extended spectrum beta lactamase (ESBL)--and non-ESBL-producing uropathogenic E. coli.Human bladder uroepithelial cells synergize with monocytes to promote IL-10 synthesis and other cytokine responses to uropathogenic Escherichia coli.Expression and antimicrobial function of beta-defensin 1 in the lower urinary tract The UPEC pore-forming toxin α-hemolysin triggers proteolysis of host proteins to disrupt cell adhesion, inflammatory, and survival pathways.Role of Uropathogenic Escherichia coli Virulence Factors in Development of Urinary Tract Infection and Kidney Damage.ATG16L1 deficiency in macrophages drives clearance of uropathogenic E. coli in an IL-1β-dependent manner Induction of indoleamine 2,3-dioxygenase by uropathogenic bacteria attenuates innate responses to epithelial infection.Genome-wide mapping of cystitis due to Streptococcus agalactiae and Escherichia coli in mice identifies a unique bladder transcriptome that signifies pathogen-specific antimicrobial defense against urinary tract infection.A Murine Model for Escherichia coli Urinary Tract Infection.YbcL of uropathogenic Escherichia coli suppresses transepithelial neutrophil migration.Cytotoxic necrotizing factor 1 and hemolysin from uropathogenic Escherichia coli elicit different host responses in the murine bladder Inactivation of host Akt/protein kinase B signaling by bacterial pore-forming toxins.Association of O-Antigen Serotype with the Magnitude of Initial Systemic Cytokine Responses and Persistence in the Urinary Tract.Molecular basis of uropathogenic Escherichia coli evasion of the innate immune response in the bladder.Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.Molecular epidemiology and phylogenetic distribution of the Escherichia coli pks genomic island.Uropathogenic Escherichia coli-Associated Exotoxins Abnormal immunological profile and vaginal microbiota in women prone to urinary tract infections.TLR-mediated immune responses in the urinary tract.Urothelial cultures support intracellular bacterial community formation by uropathogenic Escherichia coli Uropathogenic Escherichia coli-induced inflammation alters mouse urinary bladder contraction via an interleukin-6-activated inducible nitric oxide synthase-related pathway.Interleukin-8 is essential for normal urothelial cell survival.Lipopolysaccharide Domains Modulate Urovirulence.Quantitative assessment of human neutrophil migration across a cultured bladder epithelium The Adherent/Invasive Escherichia coli Strain LF82 Invades and Persists in Human Prostate Cell Line RWPE-1, Activating a Strong Inflammatory Response.IL-8 and global gene expression analysis define a key role of ATP in renal epithelial cell responses induced by uropathogenic bacteria.Immunity to uropathogens: the emerging roles of inflammasomes.Protein-based profiling of the immune response to uropathogenic Escherichia coli in adult patients immediately following hospital admission for acute cystitis.Granulocyte-macrophage colony-stimulating factor (GM-CSF) is released by female mouse bladder urothelial cells and expressed by the urothelium as an early response to lipopolysaccharides (LPS).Uropathogenic Escherichia coli Engages CD14-Dependent Signaling to Enable Bladder-Macrophage-Dependent Control of Acute Urinary Tract Infection.A novel ex vivo set-up for dynamic long-term characterization of processes on mucosal interfaces by confocal imaging and simultaneous cytokine measurements.

P2860

Q26770272-31F244B1-4389-418D-85A3-FB688709FE3B Q27008499-A28B4A3D-E8F9-4A09-90F3-7A9F764A52A8 Q27346708-5FC570B0-965C-41C0-A656-D47AE5E971B3 Q28569184-6F020FC6-DE78-4ADF-83C5-4E3F2FC469E2 Q30446364-1ADAF272-E9E1-4BBB-A997-6C4CB58159FF Q33613902-9B2F01DA-1074-43BB-939E-2260766DE1E1 Q34562945-A6848295-81C4-4910-B4EE-859FC4233B18 Q34975465-6BEA1617-BA3C-4A69-AAC5-5A17C727E559 Q34995541-D9FAD15F-2005-4721-99F7-438F6338D662 Q35025542-50493997-8252-49C4-9CBA-9357A5C9A6BE Q35035519-ACD2256C-70E2-42DD-9E54-D819BDFB703F Q35697535-4040A785-F817-4BB0-AD6F-E99F2EF0EB87 Q35852635-CD8DAC9D-1460-4B88-8436-0B0AB48558AE Q35941046-0914F16F-E498-4FC6-8F32-02725E02B169 Q36154064-F314E210-E84D-4671-9577-E41F22651FEA Q36163174-2F318AF4-4F8D-4FFB-8C0A-942BCDF13354 Q36219597-E92BEC5D-4CA1-42C2-AEC8-D88584485CEE Q36396917-5BA0DF91-1454-4C47-A452-0761D465B2E0 Q36506173-9204C869-11D8-4609-A341-E2E7CA540890 Q36536668-98D66AE4-C7CD-465C-B2B1-ECC31B551F66 Q36634934-085AD3A4-7813-465C-9E58-C5D8E21DE82D Q36845149-F07D9A48-4618-4628-B3C6-179CCD1E6AEB Q36910650-5948B49F-FBD5-41A1-B228-116998B1E926 Q36951570-C6385171-4FD8-4583-A934-F9BDE94F3415 Q36994573-E6584C3F-6E2D-4620-9A36-AEA8B1E62E8E Q37035981-3DDFE00C-0060-4126-820B-4196008FA58D Q37051041-484C7476-98BD-46BB-9108-4D015E1588B9 Q37074933-668B08B2-0A2B-4C54-9F99-C7FEB37D9316 Q37256577-6FA1AD33-4A5A-46C5-AF5B-4C59F587135B Q37274828-6C7375DB-6BD4-4E0C-9F44-092495871D3E Q37337368-E43B4CDA-B7A0-45AB-A132-7D95E498B38E Q37345901-2B21B66C-A92D-4E0A-9938-6464C21E8DCB Q37602461-C9F25DBF-179F-4DFF-90A9-28D1DB0EE1A2 Q38747897-220D902C-DDC7-4094-BA09-3AEA0A6C2E43 Q38996053-E01F689A-FEC3-4232-9CDF-CB09231282F3 Q39165446-8DE1DA42-84F7-4958-B560-7EB9D33C626D Q39647186-93707C51-6323-470D-9A83-1F069119D4B4 Q40639060-0180213A-CE48-4F88-9E78-763EF392D873 Q41022801-4E5568A0-9AEC-4E5D-8C18-252D2F5E79C2 Q42486802-35BF116C-B65F-47F9-824A-59F092590C15

P2860

Modulation of host innate immune response in the bladder by uropathogenic Escherichia coli.

http://www.wikidata.org/entity/Q36313895

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Modulation of host innate immu ...... ropathogenic Escherichia coli.

@ast

Modulation of host innate immu ...... ropathogenic Escherichia coli.

@en

type

label

Modulation of host innate immu ...... ropathogenic Escherichia coli.

@ast

Modulation of host innate immu ...... ropathogenic Escherichia coli.

@en

prefLabel

Modulation of host innate immu ...... ropathogenic Escherichia coli.

@ast

Modulation of host innate immu ...... ropathogenic Escherichia coli.

@en

P1433

Q36313895-68C99CDF-3B46-4F0F-9D57-A48E04FA53BE

P1476

Q36313895-622BD2D6-4209-4DEE-ADB2-8AEC542D3D66

P2093

Q36313895-582B04C2-083E-4CCA-9023-8E569F35FD78

Q36313895-901A22C2-0C9C-48EB-B61C-2BBDC6AE56F2

Q36313895-B6A1337E-BC73-4052-9257-28076FFA26EB

Q36313895-E7E1D9B5-53D1-4848-82FF-DF3CF99E67D0

Q36313895-F6CAF0C6-9C5D-49C5-91AB-887C45E7E1E5

P2860

Q36313895-1184FD11-3064-4791-A39B-F291CAB7586B

Q36313895-159CDD4A-A840-4784-9603-655C6BC4DFBB

Q36313895-25E74726-2408-4DBF-9D5A-4D79DAFE8D87

Q36313895-2A9CDD42-52EC-4AC6-BDFB-6BE5CB0FCFBC

Q36313895-2D126240-E341-499E-8793-33DE522C8D87

Q36313895-30EC3E6E-D86A-4107-B809-6D7CF64A6AB2

Q36313895-310623B8-DF92-42D8-B81B-B7AA1A6A52F2

Q36313895-4368BA9E-1FD6-4746-8F84-ED3BFFAC4020

Q36313895-48C37E03-6CC2-4C9E-8D10-7BC0A456E3D5

Q36313895-4C519547-560A-440F-934E-AD06A960E796

P304

Q36313895-F534648E-A436-4918-A803-CCD9B31E9E6B

P31

Q36313895-A745876F-1B88-4893-81B0-C5D2BFDD75F4

P356

Q36313895-D4BCBD0C-B39F-4A8A-AB87-3DA8BCAB915A

P407

Q36313895-D51B0CE9-6295-4F54-94C6-1A87941BB15E

P433

Q36313895-5583958B-20A2-493C-8B99-5345EE6D276F

P478

Q36313895-F6558DBD-32E7-4721-8D36-C0B517062B6F

P50

Q36313895-C9865822-1AB2-42A8-BBAB-57E7D39EEE1F

P577

Q36313895-62F10316-099B-4143-BDC5-C0F34E9ABBD8

P5875

Q36313895-E23F6C5B-C78E-4A76-88DA-2E5118EFEDD3

P698

Q36313895-941E3ED3-D02A-483E-A2D8-FC149F53CFC1

P921

Q36313895-B37C4446-C92D-450F-8FC0-9C369B859C1C

P932

Q36313895-73FAF660-27FD-45E6-BD5A-D10CFEC9DCAD

P356

P1433

Infection and Immunity

P1476

Modulation of host innate immu ...... ropathogenic Escherichia coli.

@en

P2093

Anthony J Schaeffer

http://www.w3.org/2001/XMLSchema#string

Benjamin K Billips

http://www.w3.org/2001/XMLSchema#string

David J Klumpp

http://www.w3.org/2001/XMLSchema#string

Matthew T Rycyk

http://www.w3.org/2001/XMLSchema#string

Sarah G Forrestal

http://www.w3.org/2001/XMLSchema#string

P2860

Filamentation by Escherichia coli subverts innate defenses during urinary tract infection

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

The complete genome sequence of Escherichia coli K-12

Pathogen recognition and innate immunity

Inhibition of the mitogen-activated protein kinase kinase superfamily by a Yersinia effector

Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination

Virulence factors in Escherichia coli urinary tract infection

Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis.

Suppression of bladder epithelial cytokine responses by uropathogenic Escherichia coli.

Interleukin-8 and the neutrophil response to mucosal gram-negative infection.

P304

5353-5360

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/IAI.00922-07

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

75

http://www.w3.org/2001/XMLSchema#string

P50

James R Johnson

P577

2007-08-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6116384

http://www.w3.org/2001/XMLSchema#string

P698

17724068

http://www.w3.org/2001/XMLSchema#string

P921

Escherichia coli

P932

2168307

http://www.w3.org/2001/XMLSchema#string